Company Filing History:
Years Active: 1998
Title: Innovator Spotlight: Shiang Huang
Introduction: Shiang Huang is a prominent inventor based in San Ramon, California, known for her significant contributions to the field of hematology. With a focus on hematopoietic stem cells, her innovative work has paved the way for advancements in medical therapies.
Latest Patents: Shiang Huang holds a patent titled "Phenotypic characterization of the hematopoietic stem cell." This patent discloses one or more populations of cells enriched for human hematopoietic stem cells. The hematopoietic stem cells in this population exhibit capabilities of limited self-renewal and are proficient in differentiating into all components of the hematopoietic system. Notably, this population has the phenotype of CD34.sup.+ /CD38.sup.- and more preferably CD34.sup.+ /CD38.sup.- /HLA-DR.sup.+, along with the expression of CD13, CD33, and CD71. These hematopoietic stem cells are essential in numerous therapies, including autologous transplantation and gene therapy.
Career Highlights: Shiang Huang is currently associated with Becton Dickinson and Company Limited, a leader in medical technology that supports the advancement of healthcare. Her work reflects her commitment to research and innovation in hematopoietic stem cells, emphasizing their potential in regenerative medicine.
Collaborations: Throughout her career, Shiang has collaborated with esteemed colleagues such as Leon W. Terstappen and Michael R. Loken. Their collective expertise fosters advancements in the understanding and application of hematopoietic stem cells.
Conclusion: Shiang Huang is an influential figure in the world of medical innovations, particularly in the area of hematopoietic stem cells. Her patent work not only demonstrates her ingenuity and dedication but also holds the promise of transforming therapeutic approaches in various medical fields.